Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer.
Wei-Wei FengNan JiaHaining JiaoJun ChenYan ChenYueru ZhangMenghan ZhuChongying ZhuLifei ShenWenqing LongPublished in: Journal of translational medicine (2021)
Personalized ctDNA detection was effective and stable for high-risk EC. CtDNA tracking in post-operative plasma is valuable for predicting tumor recurrence.